Literature DB >> 26921310

Grb2 Is Important for T Cell Development, Th Cell Differentiation, and Induction of Experimental Autoimmune Encephalomyelitis.

Daniel Radtke1, Sonja M Lacher1, Nadine Szumilas1, Lena Sandrock2, Jochen Ackermann1, Lars Nitschke3, Elisabeth Zinser4.   

Abstract

The small adaptor protein growth factor receptor-bound protein 2 (Grb2) modulates and integrates signals from receptors on cellular surfaces in inner signaling pathways. In murine T cells, Grb2 is crucial for amplification of TCR signaling. T cell-specific Grb2(fl/fl) Lckcre(tg) Grb2-deficient mice show reduced T cell numbers due to impaired negative and positive selection. In this study, we found that T cell numbers in Grb2(fl/fl) CD4cre(tg) mice were normal in the thymus and were only slightly affected in the periphery. Ex vivo analysis of CD4(+) Th cell populations revealed an increased amount of Th1 cells within the CD4(+) population of Grb2(fl/fl) CD4cre(tg) mice. Additionally, Grb2-deficient T cells showed a greater potential to differentiate into Th17 cells in vitro. To test whether these changes in Th cell differentiation potential rendered Grb2(fl/fl) CD4cre(tg) mice more prone to inflammatory diseases, we used the murine Th1 cell- and Th17 cell-driven model of experimental autoimmune encephalomyelitis (EAE). In contrast to our expectations, Grb2(fl/fl) CD4cre(tg) mice developed a milder form of EAE. The impaired EAE disease can be explained by the reduced proliferation rate of Grb2-deficient CD4(+) T cells upon stimulation with IL-2 or upon activation by allogeneic dendritic cells, because the activation of T cells by dendritic cells and the subsequent T cell proliferation are known to be crucial factors for the induction of EAE. In summary, Grb2-deficient T cells show defects in T cell development, increased Th1 and Th17 cell differentiation capacities, and impaired proliferation after activation by dendritic cells, which likely reduce the clinical symptoms of EAE.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26921310     DOI: 10.4049/jimmunol.1501764

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

1.  Precise Temporal Profiling of Signaling Complexes in Primary Cells Using SWATH Mass Spectrometry.

Authors:  Etienne Caron; Romain Roncagalli; Takeshi Hase; Witold E Wolski; Meena Choi; Marisa G Menoita; Stephane Durand; Antonio García-Blesa; Ivo Fierro-Monti; Tatjana Sajic; Moritz Heusel; Tobias Weiss; Marie Malissen; Ralph Schlapbach; Ben C Collins; Samik Ghosh; Hiroaki Kitano; Ruedi Aebersold; Bernard Malissen; Matthias Gstaiger
Journal:  Cell Rep       Date:  2017-03-28       Impact factor: 9.423

2.  Evaluation of genetic susceptibility between systemic lupus erythematosus and GRB2 gene.

Authors:  Meifeng Xu; Yan Liu; Xiaoli Li; Chuantao Cheng; Yale Liu; Wei Dong; Shaoyi Du; Shengxiang Xiao
Journal:  Sci Rep       Date:  2019-07-17       Impact factor: 4.379

3.  Endogenous Expression of the Human CD83 Attenuates EAE Symptoms in Humanized Transgenic Mice and Increases the Activity of Regulatory T Cells.

Authors:  Elisabeth Zinser; Ronald Naumann; Andreas B Wild; Julia Michalski; Andrea Deinzer; Lena Stich; Christine Kuhnt; Alexander Steinkasserer; Ilka Knippertz
Journal:  Front Immunol       Date:  2019-06-25       Impact factor: 7.561

4.  Integrated identification of key immune related genes and patterns of immune infiltration in calcified aortic valvular disease: A network based meta-analysis.

Authors:  Li-Da Wu; Feng Xiao; Jin-Yu Sun; Feng Li; Yu-Jia Chen; Jia-Yi Chen; Jie Zhang; Ling-Ling Qian; Ru-Xing Wang
Journal:  Front Genet       Date:  2022-09-21       Impact factor: 4.772

5.  CAR T cells targeting tumor-associated exons of glypican 2 regress neuroblastoma in mice.

Authors:  Nan Li; Madeline B Torres; Madeline R Spetz; Ruixue Wang; Luyi Peng; Meijie Tian; Christopher M Dower; Rosa Nguyen; Ming Sun; Chin-Hsien Tai; Natalia de Val; Raul Cachau; Xiaolin Wu; Stephen M Hewitt; Rosandra N Kaplan; Javed Khan; Brad St Croix; Carol J Thiele; Mitchell Ho
Journal:  Cell Rep Med       Date:  2021-06-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.